Pharmacokinetics in children
No information
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Pyruvate dehydrogenase complex 1 |
- Oral
-
0 years
up to
18 years
[1]
-
3
- 20
mg/kg/day
in 3
- 4
doses.
-
Treatment by or after consultations with a paediatric specialist (metabolic disorders) who has experience using riboflavin for this indication.
...read more
|
| Acute treatment of glutaric aciduria, type II |
- Intravenous
-
0 years
up to
18 years
[1]
-
150
mg/day
in 3
doses.
-
Treatment by or after consultations with a paediatric specialist (metabolic disorders) who has experience using riboflavin for this indication.
...read more
|
| Glutaric aciduria, type I |
- Oral
-
0 years
up to
18 years
[1]
-
100
mg/day
in 2
doses.
-
Treatment by or after consultations with a paediatric specialist (metabolic disorders) who has experience using riboflavin for this indication
...read more
|
| 5,10-methylenetetrahydrofolate reductase (MTHFR) |
- Oral
-
1 year
up to
2 years
[1]
-
5
mg/day
in 2
- 3
doses.
-
Treatment by or after consultations with a paediatric specialist (metabolic disorders) who has experience using riboflavin for this indication
...read more
-
2 years
up to
18 years
[1]
-
5
- 10
mg/day
in 2
- 3
doses.
-
Treatment by or after consultations with a paediatric specialist (metabolic disorders) who has experience using riboflavin for this indication
...read more
|
| ETF, responsive to vitamin B2 |
- Oral
-
0 years
up to
18 years
[1]
-
100
- 300
mg/day
in 3
doses.
-
Treatment by or after consultations with a paediatric specialist (metabolic disorders) who has experience using riboflavin for this indication.
...read more
|
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
OTHER PLAIN VITAMIN PREPARATIONS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Other plain vitamin preparations |
|
|
|
A11HA02
|
Reference
-
Blau, Hoffmann, Leonard and Clarke, Physicians guide to the treatment and follow-up of metabolic diseases, Springer, 2006
Therapeutic Drug Monitoring
Overdose